SB525334 is a selective inhibitor of transforming growth factor-?? receptor I (ALK5, TGF-??RI) (IC50 = 14.3 nM). Inhibits TGF-??1-induced smad2/3 nuclear localization and TGF-??RI-induced mRNA expression in kidney cells
More Information Supplier PageSB525334 is a selective inhibitor of transforming growth factor-?? receptor I (ALK5, TGF-??RI) (IC50 = 14.3 nM). Inhibits TGF-??1-induced smad2/3 nuclear localization and TGF-??RI-induced mRNA expression in kidney cells
More Information Supplier PageSB525334 is a selective inhibitor of transforming growth factor-?? receptor I (ALK5, TGF-??RI) (IC50 = 14.3 nM). Inhibits TGF-??1-induced smad2/3 nuclear localization and TGF-??RI-induced mRNA expression in kidney cells
More Information Supplier PageSB 431542 is a potent and specific inhibitor of transforming growth factor-?? superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 .
More Information Supplier PageSB 431542 is a potent and specific inhibitor of transforming growth factor-?? superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 .
More Information Supplier PageSB 431542 is a potent and specific inhibitor of transforming growth factor-?? superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 .
More Information Supplier PageSB 743921, a second generation KSP inhibitor, is a highly potent and active therapeutic in preclinical models of cancer.
More Information Supplier PageSB 743921, a second generation KSP inhibitor, is a highly potent and active therapeutic in preclinical models of cancer.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier Page
